QSAR analysis of cyclooxygenase inhibitors selectivity index (COX1/COX2): Application of SVM-RBF and MLR methods

Pharmaceutical Sciences

Volumn 21, Issue 2, 2015, Pages 86-93

  Tatardar, Siavash ^a   Jouyban, Abolghasem ^b   Soltani, Somaieh ^b   Zakariazadeh, Mostafa ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

COX Inhibitor; MLR; QSAR; Selectivity Index; SVM RBF

Indexed keywords

BENZOPYRAN DERIVATIVE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NIMESULIDE; SULFONAMIDE; TETRAZOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ADVERSE OUTCOME; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG SELECTIVITY; HUMAN; MULTIPLE LINEAR REGRESSION ANALYSIS; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RANDOMIZATION; SUPPORT VECTOR MACHINE;

EID: 84945335397     PISSN: 1735403X     EISSN: 23832886     Source Type: Journal    
DOI: 10.15171/PS.2015.22     Document Type: Article

References (27)

1. Simmons DL, Botting RM, Hla T. Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition. Pharmacol Rev 2004;56:387-437. doi: 10.1124/pr.56.3.3
2. Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discov 2003;2:179-191. doi:10.1038/nrd1034
3. Zarghi A, Arfaei S. Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships. Iran J Pharm Res 2011;10:655-683.
4. Asit K. Chakraborti SKG, Raj Kumar, Hashim F. Motiwala and Pradeep S. Jadhavar. Progress in COX-2 Inhibitors: A Journey So Far. Curr Med Chem 2010;17:1563-1593. doi: 10.2174/092986710790979980
5. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001;357:539-545. doi:10.1016/S0140-6736(00)04046-0
6. Harris R, Beebe, Alshafie. Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. J Exp Pharmacol 2012;4:91-96. doi:10.2147/JEP.S23826
7. Khan Z, Khan N, Tiwari RP, Sah NK, Prasad GB, Bisen PS. Biology of Cox-2: an application in cancer therapeutics. Current drug targets 2011;12:1082-1093. doi:10.2174/138945011795677764
8. Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010;29:781-788. doi:10.1038/onc.2009.421
9. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease Neurobiol Aging 2000;21:383-421. doi:10.1016/S0197-4580(00)00124-X
10. Soltani S, Abolhasani H, Zarghi A, Jouyban A. QSAR analysis of diaryl COX-2 inhibitors: Comparison of feature selection and train-test data selection methods. Eur J Med Chem 2010;45:2753-2760. doi:10.1016/j.ejmech.2010.02.055
11. Qiu KM, Yan R, Xing M, Wang H-H, Cui H-E, Gong H-B, et al. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors. Bioorg Med Chem 2012;20:6648-6654. doi:10.1016/j.bmc.2012.09.021
12. Li Y, Chen SH, Ou TM, Tan JH, Li D, Gu LQ, et al. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase. Bioorg Med Chem 2011;19:2074-2083. doi:10.1016/j.bmc.2011.01.043
13. Lu X, Zhang H, Li X, Chen G, Li QS, Luo Y, et al. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors. Bioorg Med Chem 2011;19:6827-6832. doi:10.1016/j.bmc.2011.09.034
14. Xing L, Hamper BC, Fletcher TR, Wendling JM, Carter J, Gierse JK, et al. Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors. Bioorg Med Chem Lett 2011;21:993-996. doi:10.1016/j.bmcl.2010.12.023
15. Al-Hourani BJ, Sharma SK, Mane JY, Tuszynski J, Baracos V, Kniess T, et al. Synthesis and evaluation of 1, 5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 2011;21:1823-1826. doi:10.1016/j.bmcl.2011.01.057
16. Abdur Rahim M, Praveen Rao PN, Bhardwaj A, Kaur J, Huang Z, Knaus EE. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors. Bioorg Med Chem Lett 2011;21:6074-6080. doi:10.1016/j.bmcl.2011.08.053
17. Kaur J, Bhardwaj A, Huang Z, Knaus EE. N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: Synthesis and biological evaluation. Bioorg Med Chem Lett 2012;22:2154-2159. doi:10.1016/j.bmcl.2012.01.130
18. Zarghi A, Reihanfard H, Arfaei S, Daraei B, Hedayati M. Design and synthesis of new 1, 2-diaryl-4, 5, 6, 7-tetrahydro-1H-benzo[d] imidazoles as selective cyclooxygenase (COX-2) inhibitors. Med Chem Res 2012;21:1869-1875. doi:10.1007/s00044-011-9709-y
19. Liang Y, Xu Q, Li H, Cao D. Support Vector Machines and Their Application in Chemistry and Biotechnology, CRC press, FL, USA;2011.
20. Soltani S, Haghaei H, Shayanfar A, Vallipour J, Asadpour Seynali K, Jouyban A. QSBR Study of Bitter Taste of Peptides: Application of GA-PLS in Combination with MLR, SVM, and ANN Approaches. BioMed Res Int 2013;501310. doi:10.1155/2013/501310
21. Hernández N , Kiralj R, Ferreira MMC, Talavera I. Critical comparative analysis, validation and interpretation of SVM and PLS regression models in a QSAR study on HIV-1 protease inhibitors. Chemom Intell Lab Syst 2009;98:65-77. doi:10.1016/j.chemolab.2009.04.012
22. Fernandez M, Caballero J, Fernandez L, Sarai A. Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM). Mol Diver 2011;15:269-289. doi:10.1007/s11030-010-9234-9
23. Tresadern G, Cid JM, Trabanco AA. QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators. J Mol Graph Model 2014;53:82-91. doi:10.1016/j.jmgm.2014.07.006
24. Jahangiri R, Soltani S, Barzegar A. A Review of QSAR Studies to Predict Activity of ACE Peptide Inhibitors.Pharm Sci 2014;20:122-129.
25. Darnag R, Minaoui B, Fakir M. Application of support vector machines for prediction of anti-HIV activity of TIBO Derivatives. Chem Mater Res 2013;3:119-124. doi.org/10.1016/j.ejmech.2010.01.002
26. Gaspar P, Carbonel J, Oliveira JL. On the parameter optimization of Support Vector Machines for binary classification. J Integr Bioinform 2012;9:201. doi: 10.2390/biecoll-jib-2012-201.
27. Huang CL, Wang CJ. A GA-based feature selection and parameters optimizationfor support vector machines. Expert Syst appl 2006;31:231-240. doi:10.1016/j.eswa.2005.09.024